MTP-131
Sponsors
Stealth BioTherapeutics Inc.
Conditions
Age-related Macular DegenerationCongestive Heart FailureDiabetic Macular EdemaHeart FailureNormal and Impaired Renal Function
Phase 1
A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration
CompletedNCT02314299
Start: 2014-11-30End: 2015-06-30Updated: 2015-10-26
A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Bendavia™ (MTP-131) in Patients With Heart Failure
WithdrawnNCT02388529
Start: 2015-05-31End: 2015-10-31Updated: 2015-10-15
A Study Investigating the Safety, Tolerability, and Pharmacokinetics of MTP-131 in Subjects With Congestive Heart Failure
CompletedNCT02388464
Start: 2014-07-31End: 2015-06-30Updated: 2015-09-17
A Phase 1 Study Investigating the Safety and Pharmacokinetics of Repeat-dose Intravenous Infusion of MTP-131 in Subjects With Impaired Renal Function
CompletedNCT02436447
Start: 2015-05-31End: 2015-10-31Updated: 2015-11-18